Related Experiment Video
Updated: Mar 30, 2026

09:34
Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
35.0K
DNAJC6 Mutations Associated With Early-Onset Parkinson's Disease
Simone Olgiati1, Marialuisa Quadri1, Mingyan Fang2
1Department of Clinical Genetics, Erasmus MC, Rotterdam, the Netherlands.
Annals of Neurology
|November 4, 2015
Summary
Mutations in the DNAJC6 gene are linked to a new form of early-onset Parkinson's disease (PD). This discovery highlights the role of synaptic vesicle endocytosis in PD pathogenesis.
Area of Science:
- Genetics
- Neuroscience
- Molecular Biology
Background:
- Mutations in DNAJC6 have been previously identified in families with autosomal recessive juvenile parkinsonism.
- These cases presented with early onset, atypical symptoms, and rapid progression.
Purpose of the Study:
- To investigate the role of DNAJC6 mutations in early-onset Parkinson's disease (PD).
- To identify novel mutations in DNAJC6 associated with PD and characterize the associated phenotype.
Main Methods:
- Analyzed the DNAJC6 gene in 274 patients with early-onset PD.
- Utilized cosegregation analysis, homozygosity mapping, linkage analysis, whole-exome sequencing, and protein studies.
- Assessed auxilin protein levels in patient fibroblasts.
Main Results:
- Identified two families with novel homozygous DNAJC6 mutations linked to PD.
- Patients exhibited decreased auxilin protein levels and symptoms consistent with early-onset PD.
- A sporadic case with noncoding DNAJC6 variants potentially affecting RNA splicing was also identified.
Conclusions:
- Established a novel form of hereditary early-onset PD associated with DNAJC6 mutations.
- Recommend screening DNAJC6 in early-onset PD patients with suspected autosomal recessive inheritance.
- These findings underscore the importance of synaptic vesicle endocytosis and trafficking in PD pathogenesis.
Related Concept Videos
Parkinson's Disease: Overview
2.4K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.4K
Point and Frameshift Mutations
1.6K
Point mutations are genetic alterations involving the change of a single nucleotide base pair in DNA. Depending on how the alteration affects protein synthesis, they can lead to various consequences.Point mutations fall into the following types:Silent mutations occur when a nucleotide change does not alter the amino acid sequence due to the redundancy of the genetic code. For instance, changing ACC to ACA still encodes threonine, leaving the protein function unaffected. This occurs because...
1.6K
Single Nucleotide Polymorphisms-SNPs
19.8K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
19.8K
Parkinson's Disease: Treatment
1.3K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K
Mutations
45.5K
Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
45.5K
Mutations
96.4K
Overview
96.4K

